HICOOL 2025

perfect ending

From October 16th to 18th, 2025, the HICOOL 2025 Global Entrepreneur Summit with the theme of "Building a Global Innovation and Entrepreneurship Ecological Capital" will grandly kick off in Beijing. In the world-class university exhibition area established for the first time at this summit, the Academician Project Zone became the focus of the entire event with seven academicians personally leading teams to transform cutting-edge scientific and technological achievements. Beijing Chaoweijing Biotechnology Co., Ltd. (hereinafter referred to as "Chaoweijing") made a brilliant appearance, showcasing China's independent innovation breakthroughs in the field of biomedical imaging with the disruptive imaging technology achievements led by Academician Cheng Heping.

Beijing Chaoweijing Biotechnology Co., Ltd. was founded by an interdisciplinary team from Peking University, thanks to the scientific and technological achievements transformation of the National Natural Science Foundation of China's major research instrument and equipment development project. Chaoweijing always focuses on the research and development of high-end life science instruments and the development of innovative medical devices. With continuous technological breakthroughs, it continuously injects innovative power into global life science research and clinical medicine.

Breaking foreign monopolies

Leading the way in miniaturized multiphoton microscopy imaging technologyglobal

　　In the high-end scientific instrument field, in 2017, a super high spatiotemporal resolution miniaturized two-photon microscope with a probe of only 2.2 grams was successfully developed, which was named one of the "Top Ten Scientific Advances in China in 2017" and became the first Chinese team to win the "Nature Methods" annual method award. Ultra dimensional anchoring with independent controllability has successfully solved the bottleneck of localization of key components such as miniaturized probes, special fibers, and femtosecond lasers, breaking the technological monopoly of foreign countries in this field. It has also launched four generations of miniaturized multiphoton microscopes, each of which maintains a global leading level. At present, the miniaturized multiphoton microscopy imaging system of Super Vision has been widely used in top research institutions such as Peking University, Tsinghua University, Harvard University, Johns Hopkins University, Oxford University, and Max Planck Institute in Germany. It has become a research tool for global scientists to analyze neural circuits and explore the mechanisms of brain diseases, helping to produce multiple breakthrough achievements in the global life science field and providing key support for humanity's journey to uncover the mysteries of the brain.

Promote clinical translation

Embark on a new track of precision medicine

Based on its profound accumulation in the field of multiphoton technology, Super Vision is promoting the extension of this technology to clinical medical scenarios. In 2023, it was approved for the registration certificate of China's first medical device based on the two-photon principle. This breakthrough not only provides a new technological path for disease diagnosis, but also opens up new possibilities for precision medicine in the future. In the future, Super Vision will further expand its technological boundaries and accelerate its layout in cutting-edge fields such as non-invasive in vivo pathology detection, brain computer interfaces, and AI assisted diagnosis, launching more innovative medical device products and injecting more innovative vitality into people's lives and health.

look around the world

Establish domestic high-end productsA model of scientific instruments going abroad

Chaoweijing insists on rooting itself in China, serving the country's technological innovation and development, while actively expanding into the global market. With leading technological strength and reliable product quality, its products have successfully entered the high-end scientific research market in Europe and America, and have accumulated orders worth tens of millions of yuan overseas. This achievement not only realizes the "reverse export" of high-end domestic life science instruments to developed countries, but also breaks the pattern of foreign brands dominating the global market for a long time, making Super Vision a phenomenon level enterprise of domestic high-end scientific instruments "going global".

　　Currently, a new round of technological revolution and industrial transformation is deepening, and China is accelerating its development in fields such as biomedicine, artificial intelligence, and digital economy, with vast space. Accelerating the development of new quality productive forces has become an important direction for promoting high-quality development. In the future, Chaoweijing will continue to deepen its core platform technology and continuously output more "Made in China" and "Chinese solutions" for global life science research and healthcare.